MarketCap
Facebook
X
Telegram
AC Immune SA EV | ACIU
EV Jährlich AC Immune SA
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 370 M | 280 M | 204 M | 240 M | 252 M | 402 M | 322 M | 148 M | 494 M | 451 M | -67.6 M | 6.83 M | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in CHF-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 494 M | -67.6 M | 258 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Kezar Life Sciences
KZR
|
-19.9 M | - | - | $ 53.3 M |  USA |
 |
Lixte Biotechnology Holdings
LIXT
|
23.7 M | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-13.6 M | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
640 M | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-4.49 M | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
45.6 M | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
7.43 M | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
209 M | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
388 M | $ 9.17 | 5.04 % | $ 636 M | USA |
 |
BiomX
PHGE
|
4.2 M | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-26.4 M | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
30.6 M | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
-3.53 M | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-19.3 M | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
32.1 M | - | -6.08 % | $ 184 M |  China |
 |
Cassava Sciences
SAVA
|
51.3 M | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
298 M | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
140 M | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-5.54 M | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
27.3 M | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-1.02 M | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
9.8 M | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-14.7 M | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
8.75 M | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-5.57 M | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
187 M | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
416 M | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-9.3 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
66.6 M | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
81.3 M | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
1.47 B | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-3.96 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-4.64 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-5.65 M | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
30.9 M | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
-49.7 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-26.7 M | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
68.7 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
44 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
2.82 B | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-72 M | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
673 M | $ 4.2 | -0.36 % | $ 651 M | USA |
 |
AbbVie
ABBV
|
394 B | $ 294.72 | 0.32 % | $ 521 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
-795 K | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Avenue Therapeutics
ATXI
|
-1.76 M | - | -52.27 % | $ 4.45 M | USA |